HELP released a discussion draft of its legislation to reauthorize FDA user fees for drugs, biologics, and medical devices package, which includes the controversial and divisive Durbin-Braun premarket approval concept and more that would be damaging to the industry.
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.
